Clinical Trials in Baltimore

Showing 2521-2540 of 11,213 trials

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

NCT02407431

The purpose of the PaTH Network IPF Clinician-Patient Partnership Cohort is to use clinical data from electronic health records (EHR) and patient reported outcomes (PRO) to answer questions of clinical importance to patients with Idiopathic Pulmonary Fibrosis, providers, and other stakeholders.

Idiopathic Pulmonary Fibrosis

University of Pittsburgh1,000 participantsStarted Mar 2015

Baltimore, Maryland, United States • Hershey, Pennsylvania, United States • Philadelphia, Pennsylvania, United States +2 more locations

RECRUITINGPhase 3< 1 mile

Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

NCT06375811

A Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women with endometriosis who are undergoing IVF, with a primary outcome of live birth rate. The investigators' central hypothesis is that in infertile woman with endometriosis undergoing in vitro fertilization-embryo transfer (IVF-ET), live birth rates will improve in those pretreated with GnRH antagonist compared to those not pretreated with GnRH antagonist.

InfertilityEndometriosis

Yale University297 participantsStarted Mar 2024

Aurora, Colorado, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +2 more locations

Active Not RecruitingPhase 2< 1 mile

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

NCT01594723

The primary purpose of this study is to measure the response rate in participants with the myeloproliferative neoplasms (MPNs), polycythemia vera (PV), essential thrombocythemia (ET), or myelofibrosis (MF) when treated with LY2784544, including those who have demonstrated an intolerance to, failure of primary response to, or have demonstrated disease progression while on ruxolitinib.

Neoplasms, Hematologic

Eli Lilly and Company110 participantsStarted May 2012

Rogers, Arkansas, United States • Burbank, California, United States • Norwalk, Connecticut, United States +36 more locations

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Find Trials by Condition in Baltimore

Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types

Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

Assistance Delivery and Muscle Coordination

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS